Cancer Dx expansion and inVue Dx FNA combine preventive screening and rapid, in-clinic diagnosis, enabling veterinarians and pet owners to act with confidence The IDEXX inVue Dx analyzer, featuring a ...

cDepartment of Surgery, Division of Pediatric Surgery, University of Utah, Primary Children's Hospital, Salt Lake City, UT, USA dDepartment of Pediatric Surgery, Children's Hospital of Colorado, ...

A new study suggests that neural crest cells are reprogrammed into tumor-forming cells, reshaping the understanding of this childhood cancer. LOS ANGELES--(BUSINESS WIRE)--A groundbreaking study led ...

Mast cell tumors (MCTs) are among the most common skin cancers affecting dogs and cats. These tumors originate from mast cells – immune cells that play a key role in allergic reactions and ...

Spontaneous regression of cancer is an uncommon event observed most often in neuroblastoma, leukemia, lung cancer, and melanoma. The underlying mechanisms are not fully understood; however, infections ...

1Center for Cell and Gene Therapy, Baylor College of Medicine, Houston Methodist Hospital, Texas Children’s Hospital, Houston, Texas. 2Department of Pediatrics, Baylor College of Medicine, Houston, ...

Add Yahoo as a preferred source to see more of our stories on Google. CHARLESTON, S.C. (WCBD) – From now through June 13, the community can give back by getting a haircut to raise money for Sarcoma ...

Tumors develop when cells in the body grow uncontrollably. Finding a tumor on your dog can be very frightening, but they are not always detrimental — some are benign, while others are malignant.

Meera Pal is a Northern California-based writer with a background in journalism and books. She covers pets, real estate, tech, and everything in between. You can follow her on Twitter @Meerakat Kelly ...

Letetresgene autoleucel (lete-cel) showed a 42% response rate in a phase 2 trial for synovial sarcoma and myxoid/round cell liposarcoma. The trial included 64 patients, with 41% response in synovial ...

“This is the first report of spindle cell sarcoma BRAF V600E/S607T double-mutated, responding to a combination of B-Raf and MEK inhibitors.” “This is the first report of spindle cell sarcoma BRAF ...